Čes. slov. farm. 2015, 64(1):19-24 | DOI: 10.36290/csf.2015.004
Synthesis and anti-infective evaluation of 5-amino-N-phenylpyrazine-2-carboxamides
- 1 Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy, Charles University in Prague, Hradec Králové, Czech Republic
- 2 Department of Clinical Microbiology, University Hospital, Hradec Králové, Czech Republic
A series of eleven novel 5-amino-N-phenylpyrazine-2-carboxamides were synthesized and evaluated for in vitro anti-infective properties. Prepared compounds were characterized by IR, 1H NMR and 13C NMR spectra, elementary analysis and melting points. Lipophilicity parameters Log P and ClogP were calculated. None of the compounds was effective against any of tested mycobacterial strains (Mycobacterium tuberculosis H37Rv, M. kansasii, M. avium) up to concentration of 100 μg/mL. 5-amino-N-(2,5-dimethylphenyl) pyrazine-2-carboxamide (
3) exerted moderate antibacterial activity against Staphylococcus aureus (MIC = 62.5 μM). No antifungal activity was detected. Several compounds exerted moderate antiviral activity against influenza A viruses at the level of tens of μM.
Keywords: pyrazinamide; antimycobacterial activity; antibacterial activity; antifungal activity; antiviral activity
Grants and funding:
This work was financially supported by IGA NT 13346 and SVV 260 183. Authors wish to thank Ida Dufková for performing in vitro antifungal and antibacterial screening and Assoc. Professor Lieve Naesens (Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium) for coordination of antiviral testing.
Received: February 27, 2015; Accepted: March 24, 2015; Published: January 1, 2015 Show citation
References
- WHO. Global Tuberculosis Report 2014. WHO/HTM/TB/2014.08. Available online: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?ua=1 (accessed on 26th February 2015).
- Butler M. S., Blaskovich M. A., Cooper M. A. Antibiotics in the clinical pipeline in 2013. J. Antibiot. (Tokyo) 2013; 66, 571-591.
Go to original source...
Go to PubMed...
- Zumla A. I., Gillespie S. H., Hoelscher M., Philips P. P. J., Cole S. T., Abubakar I., McHugh T. D., Schito M., Maeurer M., Nunn A. J. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect. Dis. 2014; 14, 327-340.
Go to original source...
Go to PubMed...
- Waisser K., Novotna E., Kunes J., Solarikova J. Phenyl salicylates - a new group of potential antituberculotics. Čes. slov. Farm. 2012; 61, 282-284.
- Opletalova V., Dolezel J. Thiosemicarbazones and their antimycobacterial effects. Čes. slov. Farm. 2013; 62, 78-83.
- Dolezal M., Vobickova J., Servusova B., Paterova P. Aminopyrazinoic acid esters as potential antimycobacterial drugs. Čes. slov. Farm. 2013; 62, 84-88.
- Sayahi H., Zimhony O., Jacobs W. R., Shekhtman A., Welch J. T. Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I. Bioorg Med. Chem. Lett 2011; 21, 4804-4807.
Go to original source...
Go to PubMed...
- Sayahi H., Pugliese K. M., Zimhony O., Jacobs W. R., Shekhtman A., Welch J. T. Analogs of the Antituberculous Agent Pyrazinamide Are Competitive Inhibitors of NADPH Binding to M. tuberculosis Fatty Acid Synthase I. Chem. Biodivers 2012; 9, 2582-2596.
Go to original source...
Go to PubMed...
- Shi W. L., Zhang X. L., Jiang X., Yuan H. M., Lee J. S., Barry C. E., Wang H. H., Zhang W. H., Zhang Y. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science 2011; 333, 1630-1632.
Go to original source...
Go to PubMed...
- Yang J., Liu Y., Bi J., Cai Q., Liao X., Li W., Guo C., Zhang Q., Lin T., Zhao Y., Wang H., Liu J., Zhang X., Lin D. Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide. Mol. Microbiol. 2015; 95, 791-803.
Go to original source...
Go to PubMed...
- Zumla A., Nahid P., Cole S. T. Advances in the development of new tuberculosis drugs and treatment regimens. Nature Reviews Drug Discovery 2013; 12, 388-404.
Go to original source...
Go to PubMed...
- Zitko J., Servusova B., Janoutova A., Paterova P., Mandikova J., Garaj V., Vejsova M., Marek J., Dolezal M. Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides. Bioorg Med. Chem. 2015; 23, 174-183.
Go to original source...
Go to PubMed...
- Coutts R. T., Su P., Baker G. B. Involvement of CYP2D6, CYP3A4, and other cytochrome-P-450 isozymes in N-dealkylation reactions. J. Pharmacol. Toxicol. Methods 1994; 31, 177-186.
Go to original source...
Go to PubMed...
- Coutts R. T., Foster B. C. Metabolism of amphetamines by mycobacterium-smegmatis. Can. J. Microbiol. 1980; 26, 343-349.
Go to original source...
Go to PubMed...
- Zitko J., Servusová B., Paterová P., Mandíková J., Kubíček V., Kučera R., Hrabcová V., Kuneš J., Soukup O., Doležal M. Synthesis, Antimycobacterial Activity and In Vitro Cytotoxicity of 5-Chloro-N-phenylpyrazine-2-carboxamides. Molecules 2013; 18, 14807-14825.
Go to original source...
Go to PubMed...
- Franzblau S. G., Witzig R. S., McLaughlin J. C., Torres P., Madico G., Hernandez A., Degnan M. T., Cook M. B., Quenzer V. K., Ferguson R. M., Gilman R. H. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 1998; 36, 362-366.
Go to original source...
Go to PubMed...
- Naesens L., Stephens C. E., Andrei G., Loregian A., De Bolle L., Snoeck R., Sowell J. W., De Clercq E. Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses. Antiviral Res. 2006; 72, 60-67.
Go to original source...
Go to PubMed...
- Naesens L., Vanderlinden E., Roth E., Jeko J., Andrei G., Snoeck R., Pannecouque C., Illyes E., Batta G., Herczegh P., Sztaricskai F. Anti-influenza virus activity and structure-activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains. Antiviral Res. 2009; 82, 89-94.
Go to original source...
Go to PubMed...
- Vanderlinden E., Goktas F., Cesur Z., Froeyen M., Reed M. L., Russell C. J., Cesur N., Naesens L. Novel Inhibitors of Influenza Virus Fusion: Structure-Activity Relationship and Interaction with the Viral Hemagglutinin. J. Virol. 2010; 84, 4277-4288.
Go to original source...
Go to PubMed...
- Servusova B., Vobickova J., Paterova P., Kubicek V., Kunes J., Dolezal M., Zitko J. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides. Bioorg Med. Chem. Lett 2013; 23, 3589-3591.
Go to original source...
Go to PubMed...